APA (7th ed.) Citation

MF, S., AA, M., MS, I., & SW, B. (2013). Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia. Molecular diagnosis & therapy, 17(5), 299. https://doi.org/10.1007/s40291-013-0038-3

Chicago Style (17th ed.) Citation

MF, Shabana, Mishriki AA, Issac MS, and Bakhoum SW. "Do MDR1 and SLCO1B1 Polymorphisms Influence the Therapeutic Response to Atorvastatin? A Study on a Cohort of Egyptian Patients with Hypercholesterolemia." Molecular Diagnosis & Therapy 17, no. 5 (2013): 299. https://doi.org/10.1007/s40291-013-0038-3.

MLA (9th ed.) Citation

MF, Shabana, et al. "Do MDR1 and SLCO1B1 Polymorphisms Influence the Therapeutic Response to Atorvastatin? A Study on a Cohort of Egyptian Patients with Hypercholesterolemia." Molecular Diagnosis & Therapy, vol. 17, no. 5, 2013, p. 299, https://doi.org/10.1007/s40291-013-0038-3.